Little Lumens Project is building the foundational knowledge commons for pediatric glaucoma basic science — organizing what's known about how young eyes respond to glaucomatous stress, and making the gaps impossible to ignore. The mechanism remains unresolved in children being treated today.
A neutral home for the basic science that pediatric glaucoma research has lacked.
Glaucoma following cataract surgery is one of the most serious complications of pediatric eye surgery — and its mechanism remains formally unresolved. Not because the science doesn't exist, but because it has never been gathered in one place around the right question.
The findings are scattered across decades of animal-model research, developmental biology, and emerging stem-cell work — much of it conducted in young eyes, where age-specific results were understandably read as confounding variables for adult-focused questions, rather than as the primary signal they represent for pediatric glaucoma.
Little Lumens Project organizes that knowledge: curating findings, connecting them across the causal chain, and mapping exactly where understanding breaks down. We build the commons. We hold no publishing or patenting stake in what it reveals.
We start with glaucoma following cataract surgery (GFCS) — a specific, unresolved question with a clear causal chain. The deeper question it opens onto, how young eyes respond to glaucomatous stress, reaches across pediatric glaucoma. The commons is built to grow with it.
Little Lumens Project holds no commercial, publishing, or patenting stake in what the commons reveals — by design. The science belongs to the field, not to industry.
The incentives that fund research data are less oriented toward this problem. The same forces that explain the gap are why an independent, nonprofit commons is the right entity to fill it.
Pediatric glaucoma is rare, and children are largely treated with medications developed and approved for adults. The commercial and regulatory forces that build research data are less concentrated here than in adult disease — which is exactly the gap a neutral, nonprofit commons exists to fill.
The glaucoma datasets built since 2020 grew substantially — and explicitly exclude patients under 18. The pediatric population was left further behind.
Decades of animal studies used young eyes — and the differences that came with youth were set aside as a limitation for adult-focused work. That data has not yet been organized around the question it can answer: the pediatric one.
Clinical networks work downstream. Funders focus on adults. The pre-clinical, pediatric-specific knowledge layer sits in the gap between every existing organization.
The commons doesn't just store what's known. It connects findings across the causal chain and makes the unknowns explicit — turning a scattered literature into a resource that points researchers toward the questions that matter.
Every finding tagged with its model type, species, age, and provenance — so results can be compared on equal terms for the first time.
Unknowns are first-class entries, not footnotes. The commons maps where no animal model, organoid, or pre-clinical evidence yet exists.
Built on trusted open-science infrastructure, designed for researchers to browse, cite, and contribute — and to grow as the field does.
From scattered literature to a map of what we know — and what we don't.
The young eye before surgery: trabecular meshwork immaturity, angle development, genetic predisposition.
Age at surgery, lens status, technique, anesthetic agents, and postoperative complications.
Synechiae, iris insertion, membranous obstruction, and shifts in aqueous humor composition.
How the immature eye's pressure regulation and neural tissue respond to the combined insult. The core unknown.
The first version of the commons is being seeded now. We're inviting a small number of clinicians and basic scientists to shape it — to test whether it shows them something they couldn't see before, and to help define what it becomes.
A personal connection to this cause is what brought me to it — and what keeps it moving. My background is in systems and program work: building the connective tissue that lets people and information move toward a shared goal. That's the discipline this problem needs — a neutral home that organizes what the field already knows and makes the gaps legible. Little Lumens Project exists to be that home: to build the research infrastructure pediatric glaucoma has gone without.
If you're a researcher, clinician, or potential collaborator, I'd welcome the conversation — whether about the pilot, the science, or how this fits alongside what you're building.